---
title: Lotus Clinical Research vs YPrime
slug_a: lotuscr
slug_b: yprime
site: cro
review_signal_gate: closed
canonical_path: /compare/lotuscr/yprime
generated_by: BioBM Editorial AI
---

# Lotus Clinical Research vs YPrime

This comparison is auto-generated by BioBM Editorial AI and intended as an evidence-oriented side-by-side reference.

## Company A

Lotus Clinical Research (lotuscr) is listed for cro. Specialized CRO supporting clinical development in neuroscience and metabolic disease across all phases, with direct access to 20 wholly-owned US research sites and 400+ beds.

Services: 15. Modalities: 0. Indications: 4. Locations: 3. Certifications: 0. Directory-wide review aggregates for this site are withheld until the review signal gate opens. The strongest documented coverage currently appears in services (15).

Review summary: Review summary withheld until site-level review gate opens.

## Company B

YPrime (yprime) is listed for cro. YPrime delivers configurable eCOA, IRT, and eConsent clinical trial technology platforms with consulting services, supporting ~1,000 studies globally across 19+ therapeutic areas.

Services: 10. Modalities: 0. Indications: 7. Locations: 0. Certifications: 0. Directory-wide review aggregates for this site are withheld until the review signal gate opens. The strongest documented coverage currently appears in services (10).

Review summary: Review summary withheld until site-level review gate opens.